Active ingredientCarisoprodolCat. No. P-C056-001CAS 78-44-4Family · Pharmaceutical analytical standards
Carisoprodol
A centrally acting muscle relaxant developed in the late 1950s in the United States by pharmacologist Frank Berger, starting from the structure of meprobamate. It is used for short periods against painful muscle spasms. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Chemically it differs from meprobamate, an anti-anxiety drug of the 1950s, only by an isopropyl group attached to a nitrogen: and the liver partly converts it back into meprobamate.
Go to the active ingredient →Active ingredientCarisoprodolCat. No. P-C056-001CAS 78-44-4
Pharmacopoeial impurityCarisoprodol EP Impurity ACat. No. P-C056-002CAS 25462-17-3
Pharmacopoeial impurityCarisoprodol EP Impurity BCat. No. P-C056-003CAS 7148-50-7
Pharmacopoeial impurityCarisoprodol EP Impurity CCat. No. P-C056-004CAS 78-26-2
Pharmacopoeial impurityCarisoprodol USP Related Compound ACat. No. P-C056-005CAS 1471-56-3
Isotopically labelledCarisoprodol-d3Cat. No. P-C056-006CAS 1215602-82-6
Isotopically labelledCarisoprodol-d7Cat. No. P-C056-007CAS 1218911-70-6
NitrosamineN-Nitroso CarisoprodolCat. No. P-C056-008
ImpurityCarisoprodol Impurity 1Cat. No. P-C056-009CAS 25384-75-2
Impurity2-Methylpentane-1,2-diolCat. No. P-C056-010CAS 20667-05-4
ImpurityCarisoprodol Impurity 2Cat. No. P-C056-011CAS 1729-14-2
ImpurityCarisoprodol Impurity 3Cat. No. P-C056-012
ImpurityDehydro CarisoprodolCat. No. P-C056-013CAS 2726380-15-8
Pharmacopoeial impurityCarisoprodol EP Impurity DCat. No. P-C056-014CAS 57-53-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.